Tracie Locklear to Breast Neoplasms
This is a "connection" page, showing publications Tracie Locklear has written about Breast Neoplasms.
Connection Strength
0.277
-
Klassen AF, Dominici L, Fuzesi S, Cano SJ, Atisha D, Locklear T, Gregorowitsch ML, Tsangaris E, Morrow M, King T, Pusic AL. Development and Validation of the BREAST-Q Breast-Conserving Therapy Module. Ann Surg Oncol. 2020 Jul; 27(7):2238-2247.
Score: 0.086
-
Hwang ES, Locklear TD, Rushing CN, Samsa G, Abernethy AP, Hyslop T, Atisha DM. Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy. J Clin Oncol. 2016 05 01; 34(13):1518-27.
Score: 0.065
-
Atisha DM, Rushing CN, Samsa GP, Locklear TD, Cox CE, Shelley Hwang E, Zenn MR, Pusic AL, Abernethy AP. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015 Feb; 22(2):361-9.
Score: 0.060
-
Atisha DM, Locklear TD, Rogers UA, Rushing CN, Samsa GP, Abernethy AP. Partnering with engaged patients accelerates research. J Surg Oncol. 2014 Apr; 109(5):504-5.
Score: 0.056
-
Doyle BJ, Frasor J, Bellows LE, Locklear TD, Perez A, Gomez-Laurito J, Mahady GB. Estrogenic effects of herbal medicines from Costa Rica used for the management of menopausal symptoms. Menopause. 2009 Jul-Aug; 16(4):748-55.
Score: 0.010